CYTOKINETICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Jul 2024)
What this means for you
Registered since 16 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86264078
- Registration number
- 5380852
- Mark type
- Stylized text
- Filed
- 28 Apr 2014
- Published for opposition
- 30 Sept 2014
- Registered
- 16 Jan 2018
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for the treatment of cardiovascular diseases, [ pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, ] diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness [ , infectious diseases ]
Owner
- Cytokinetics, Inc., South San Francisco, CA, US
- Cytokinetics, Inc., South San Francisco, CA, US
- Cytokinetics, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 31 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Jul 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 16 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Dec 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Nov 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Nov 2017 — USE AMENDMENT FILED
- 27 Nov 2017 — TEAS STATEMENT OF USE RECEIVED
- 09 Jun 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jun 2017 — SOU EXTENSION 5 GRANTED
- 24 May 2017 — SOU EXTENSION 5 FILED
- 07 Jun 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL